Peptide compound or pharmaceutically acceptable salt thereof
US12428446B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2020 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | May 20, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel peptide compound or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.